Gaetana Sterrantino
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV).
Journal: Journal of medical virology
Published: October 02, 2025
UNAIDS 90-90-90 Target and Retention in Care of a Cohort of Migrants Living with HIV in a Tertiary Referral Hospital in Florence, Italy.
Journal: AIDS and behavior
Published: April 02, 2025
Impact of rapid-antiretroviral therapy in a cohort of treatment-naïve migrants living with HIV in a high income setting.
Journal: International journal of STD & AIDS
Published: August 06, 2024
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.
Journal: The Journal of antimicrobial chemotherapy
Published: June 22, 2024
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, Italy.
Journal: International journal of transgender health
Published: April 29, 2024
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
Journal: Microbes and infection
Published: January 07, 2024
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes.
Journal: The Journal of infectious diseases
Published: October 25, 2023
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study.
Journal: The Journal of antimicrobial chemotherapy
Published: May 23, 2023
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
Journal: Journal of medical virology
Published: May 16, 2023
Comparing the efficacy and safety of a first-line regimen with emtricitabine/tenofovir alafenamide fumarate plus either bictegravir or dolutegravir: Results from clinical practice.
Journal: International journal of antimicrobial agents
Published: February 13, 2023
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV.
Journal: The Journal of antimicrobial chemotherapy
Published: June 26, 2022
Last Updated: 09/26/2026